Company News

The Tuberculosis Epidemic in Pakistan 

Pakistan faces a severe tuberculosis (TB) crisis, ranking fifth among high-burden countries globally. In 2021, the nation grappled with an estimated 611,000 TB cases and suffered 50,000 TB-related deaths. These staggering figures underscore the urgent need for improved detection and treatment methods to combat the Pakistan tuberculosis epidemic. 

A Global Health Concern 

The impact of TB in Pakistan extends far beyond its borders. The country contributes to nearly 5.8% of new global TB cases annually, highlighting its significance in the worldwide fight against this infectious disease. This substantial proportion emphasizes the critical importance of enhancing tuberculosis test Pakistan procedures and implementing more effective control measures. 

Diagnostic Tests for Tuberculosis Detection in Pakistan 

Innovative Screening Methods 

Pakistan is at the forefront of developing cutting-edge diagnostic tools. A blood-based multiplex microbead test for TB screening is currently in development, promising a less invasive and potentially more accessible screening option. This advancement could significantly impact early detection rates, especially in rural areas where traditional testing methods may be less available. 

A World-Class Test for Pakistan Tuberculosis Detection 

QuantiFERON®-TB Gold Plus represents a significant advancement in tuberculosis test Pakistan procedures. This innovative blood-based test has gained widespread recognition and endorsement from the World Health Organization (WHO), the United Nations (UN), and the International Pediatric Pulmonology Association (IPPA). Its adoption marks a crucial step forward in the fight against tuberculosis in Pakistan. 

Advantages Over Traditional Methods 

Unlike conventional skin tests, QuantiFERON®-TB Gold Plus offers several key benefits: 

• Higher accuracy in identifying Mycobacterium tuberculosis infections 
• Reduced potential for false-positive results 
• Faster turnaround time for results 
• No need for follow-up visits to interpret results 
• Precision in Diagnosis 

The test's ability to accurately pinpoint individuals infected with M. tuberculosis is paramount in Pakistan's tuberculosis control efforts. By providing reliable results, QuantiFERON®-TB Gold Plus enables healthcare providers to initiate timely treatment and implement effective infection control measures, ultimately contributing to reduced transmission rates and improved public health outcomes in Pakistan. 

QuantiFERON®-TB Gold Plus is proudly part of Briogene's portfolio of advanced diagnostic solutions. For more information about this innovative test and how it can enhance tuberculosis detection and control efforts, please contact us. 

Sources: 

• https://pmc.ncbi.nlm.nih.gov/articles/PMC9289334/ 
• https://www.usaid.gov/sites/default/files/2024-02/Pakistan_TB%20roadmap_narrative_22_508.pdf 
• https://www.emro.who.int/pak/programmes/stop-tuberculosis.html 
• https://pmc.ncbi.nlm.nih.gov/articles/PMC8886085/ 
• https://www.who.int/news/item/29-10-2024-tuberculosis-resurges-as-top-infectious-disease-killer 
• https://pmc.ncbi.nlm.nih.gov/articles/PMC8680181/ 
• https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023/tb-diagnosis---treatment/2.2-diagnostic-testing-for-tb 
• https://hospitals.aku.edu/pakistan/diseases-and-conditions/Pages/tuberculosis.aspx 
• https://www.qiagen.com/us/applications/tb-management 
• https://www.qiagen.com/us/applications/tb-management/tb-testing/qft-plus/workflow 
•  
•